Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 715 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
16 Мб
Скачать
xii
https://t.me/medicina_free
Contributors
MarkA.Burroughs Department of Surgery, Methodist Dallas Medical Center, Dallas, TX, USA
Kevin Carroll, MBBS Department of Surgery, Northwell Health—South Shore University Hospital, Bay Shore, NY, USA
Elisa Cassinotti, MD, PhD Department of General and Mini­mally Invasive Surgery, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
Department of Scienze Cliniche e delle Comunità, University of Milan, Milan, Italy
EdmundB.Chen, MD Department of Surgery, School of Medi­cine, Duke University, Durham, NC, USA
Anna Duprée, MD Department of General, Visceral and Tho­racic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Amr Elbakry, MD West Virginia University Department of Urology, Morgantown, WV, USA
MichaelR.Freund, MD Ellen Leifer Shulman and Steven Shul­man Digestive Disease Center, Cleveland Clinic Florida, Weston, FL, USA
Department of General Surgery, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
JackJ.Gelman, MD Department of Surgery, Division of Plastic and Reconstructive Surgery, West Virginia University School of Medicine, Morgantown, WV, USA
Barbara Diane Gillis, BS West Virginia University School of Medicine, Morgantown, WV, USA
Courtney Grifths, DO Division of Gynecology Oncology, Cooper Medical School for Rowan University, Camden, NJ, USA
Santiago Horgan, MD Department of Surgery, University of California, San Diego, San Diego, CA, USA
Contributors
https://t.me/medicina_free
xiii
DonovanHui, MD Department of Surgery, New York Medical College Metropolitan Hospital Center, New York, NY, USA
Takeaki Ishizawa, MD, PhD, FACS Department of Hepatobiliary- Pancreatic Surgery, Graduate School of Medicine, Osaka Metropolitan University, Abeno-ku, Osaka, Japan
Jillian C. Jacobson, MD Department of Surgery, UT South­western Medical Center, Dallas, TX, USA
BrendanJones, MD Department of General Surgery, West Vir­ginia University School of Medicine, Morgantown, WV, USA
Ranjeet S. Kalsi, MD Division of Pediatric General and Tho­racic Surgery, Department of Surgery, University of Pittsburgh Medical Center/Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA
JenniferKnight, MD, FACS Department of Surgery, The Ohio State University, Werner Medical Center, Columbus, OH, USA
Zachary A. Koenig, MD Department of Surgery, Division of Plastic and Reconstructive Surgery, West Virginia University School of Medicine, Morgantown, WV, USA
SachinKukreja Department of Surgery, Methodist Dallas Med­ical Center, Dallas, TX, USA
Dallas-Fort Worth Bariatrics and General Surgery, Dallas, TX, USA
Lioudmila Lipetskaia, MD, MSc Division of Urogynecology, Department of Obstetrics and Gynecology, Cooper Medical School for Rowan University, Camden, NJ, USA
PhacharaLongmeewong, MD Division of Plastic and Recon­structive Surgery, Department of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
Adam Luchey, MD West Virginia University Department of Urology, Morgantown, WV, USA
ThinzarM.Lwin, MD Department of Surgery, UC San Diego, San Diego, CA, USA
xiv
https://t.me/medicina_free
Contributors
Department of Surgical Oncology, Dana Farber Cancer Center, Boston, MA, USA
JaredMatson, MD Department of Surgery, UC San Diego, San Diego, CA, USA
DerekMuehrcke, MD, FACS Cardiovascular and Thoracic Sur­gery at Flagler Hospital, Saint Augustine, FL, USA
SamirPandya, MD Division of Pediatric Surgery, Department of Surgery, UT Southwestern Medical Center, Dallas, TX, USA
DavidPechman, MD Department of Surgery, Zucker School of Medicine at Hofstra, Northwell Health—South Shore University Hospital, Bay Shore, NY, USA
LuisQuiroga, MD, MPH Department of Surgery, Division of Plastic, Reconstructive, and Hand Surgery, West Virginia Univer­sity School of Medicine, Morgantown, WV, USA
David Renton, MD Division of General Surgery, Ohio State University, Columbus, OH, USA
HannahRinehardt, MD Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Christina Sanders, DO, MBA, FACS, FASMBS, FACOS Department of Surgery, Jacobs School of Medicine and
Biomedical Sciences, State University of NewYork at Buffalo, Buffalo, NY, USA
StefanScholz, MD Division of Pediatric General and Thoracic Surgery, Department of Surgery, University of Pittsburgh School of Medicine, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA
KeriA.Seymour, DO, MHSc Department of Surgery, School of Medicine, Duke University, Durham, NC, USA
EmanuelShapera, MD Department of Surgery, SHARP Gross­mont Hospital, La Mesa, CA, USA
Contributors
https://t.me/medicina_free
xv
IswantoSucandy, MD, FACS Department of Surgery, Advent Health Tampa, Tampa, FL, USA
PalakornSurakunprapha, MD Division of Plastic and Recon­structive Surgery, Department of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
Nova Szoka, MD, FACS, FASMBS Department of Surgery, West Virginia University, Morgantown, WV, USA
ElwinTham, MD Department of Surgery, West Virginia Univer­sity, Morgantown, WV, USA
AndreaTrinh Department of Surgery, Methodist Dallas Medi­cal Center, Dallas, TX, USA
AcaraTurner, MD Department of Surgery, Division of Plastic, Reconstructive, and Hand Surgery, West Virginia University School of Medicine, Morgantown, WV, USA
CristianeM.Ueno, MD Department of Plastic and Reconstruc­tive Surgery, Ohio State University College of Medicine, Colum­bus, OH, USA
StevenD.Wexner, MD, PhD (Hon) Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Flor­ida, Weston, FL, USA
AndrewWilliams, BS West Virginia University School of Medi­cine, Morgantown, WV, USA
Apinut Wongkietkachorn, MD, PhD Division of Plastic and Reconstructive Surgery, Department of Surgery, Faculty of Medi­cine, Mae Fah Luang University, Chiang Rai, Thailand
SupawichWongkietkachorn, MD Department of Surgery, Police General Hospital, Bangkok, Thailand
KerriWoodberry, MD, MBA, FACS Department of Surgery, Division of Plastic, Reconstructive, and Hand Surgery, West Vir­ginia University School of Medicine, Morgantown, WV, USA
xvi
https://t.me/medicina_free
Contributors
Department of Surgery, Division of Plastic and Reconstructive Surgery, West Virginia University School of Medicine, Morgan­town, WV, USA
GeneYang, MD Department of Surgery, Jacobs School of Med­icine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA
DavidZekan, MD Department of Urology, West Virginia Uni­versity, Morgantown, WV, USA
History andScience
https://t.me/medicina_free
ofImmunouorescence
LudovicaBaldari, LuigiBoni, andElisaCassinotti
Introduction
The term uorescence-guided surgery describes a medical tech­nology based on real-time imaging intended to help and guide the surgeon during their operating practice. The rst clinical use of uorescence was in 1947, when it was used for identication of brain tumors during neurosurgery using the dye uorescein. After the rst experience, other applications have been reported in sev­eral surgical elds, but uorescence-guided surgery has exponen­tially developed and spread only during the last years.
Indeed, recently, many innovations in surgical technique and minimally invasive technologies with laparoscopic, endoscopic, and robotic approaches have greatly improved surgical practice.
1
L. Baldari (*) Department of General and Minimally Invasive Surgery, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy e-mail: ludovica.baldari@policlinico.mi.it
L. Boni · E. Cassinotti Department of General and Minimally Invasive Surgery, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
Department of Scienze Cliniche e delle Comunità, University of Milan, Milan, Italy e-mail: luigi.boni@unimi.it; elisa.cassinotti@policlinico.mi.it
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 N. Szoka et al. (eds.), The SAGES Manual of Fluorescence-Guided Surgery, https://doi.org/10.1007/978-3-031-40685-0_1
1
2
https://t.me/medicina_free
Nevertheless, despite these constant advances, surgery still relies primarily on the surgeon’s vision and on white-light reectance. The emerging eld of uorescent surgical imaging promises to be a powerful enhancement to improve surgical guidance.
Among all chromophores and uorophores that could work as probes in medical imaging techniques, near-infrared uorescence imaging with indocyanine green (ICG) is emerging as the major contribution to intraoperative surgical decisions, and many differ­ent applications have already been described in literature. ICG is a dye used in medicine since the mid-1950s for a variety of diag­nostic applications in cardiology and ophthalmology and to test the hepatic clearance. However, its uorescent properties have only recently been applied to new minimally invasive surgical instrumentations. ICG has some peculiar features that promote its widespread use, like low incidence of adverse effects and very high toxic dose for the human body.
Other uorescent probes already approved for clinical use are methylene blue (MB), uorescein sodium, and 5-aminolevulinic acid (5-ALA). Moreover, many probes are currently under clini­cal development.
In addition, uorescence-guided surgery appears to have a great potential to become a standard in everyday clinical practice due to its multiple different possible applications and its ease of employment.
L. Baldari et al.
History ofImmunouorescence
From Semeiotics toFluorescence-Guided Surgery Through Medical Imaging
In clinical practice, especially in surgery, the development of a new technology needs to meet these critical criteria: to represent a true clinical requirement, the possibility to solve an open issue, and the peculiar ability not to interfere with normal clinical workow [1].
This is the reason why, before the end of the nineteenth century, the diagnostic and therapeutic process into the surgical eld relied
1 History andScience ofImmunouorescence
https://t.me/medicina_free
3
on the physician’s hands and eyes. In 1895, Wilhelm Röntgen took the rst known X-ray picture of his wife’s hand, accidentally dis­covering the X-ray [2]. Since this report, after many decades of improvements in medicine, there are few imaging techniques rou­tinely employed in clinical practice that can be divided into two main segments: optical and radiological imaging [3].
Covering the 36% of the global market, radiological imaging includes X-ray, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), and positron emission tomography (PET), and only two of these (X-ray uoroscopy and ultrasound) are used occasionally for image-guided surgery. Indeed, these techniques are mainly used for preoperative imaging that is funda­mental to plan the surgery, but it can lead to misinterpretation dur­ing the procedure due to distortion of images and the time interval between imaging and surgery (e.g., in cancer patients) [4].
Nevertheless, optical imaging covers 64% of the global mar­ket, including endoscopy, microscopy, visual surgery, ophthalmic surgery, medical lasers, and robotics-based surgery. The funda­mental of optical imaging is the use of light in the ultraviolet, visible, and near-infrared regions of the electromagnetic spec­trum, allowing diagnosis and re-evaluation more frequently as the patient is not exposed to ionizing radiation. Moreover, through varying photon absorption and light scattering from different types of tissue, optical imaging can differentiate suspicious tumoral and healthy tissues, using multiple properties of soft tis­sue [5]. One of the main areas of optical imaging is uorescence­guided surgery (FGS) in the eld of intraoperative imaging techniques. Intraoperative imaging techniques have been devel­oped to help the surgeon identify areas invisible to the naked eye. The main characteristic of an intraoperative imaging technique is the speed at which visual information is obtained.
The term “uorescence-guided surgery” describes a medical technology based on real-time imaging intended to help and guide the surgeons during their operating practice. In recent years, tech­nological progress in body imaging and diagnostics has enhanced patient selection for surgical interventions. At the same time, sur­gery has advanced substantially to decrease patient morbidity and trauma through innovations in endoscopic, laparoscopic, and
4
https://t.me/medicina_free
robotic technologies. Nevertheless, surgical practice is still based on anatomy as seen by the operating surgeon with white-light reectance. This approach does not allow an accurate differentia­tion between different tissues: in the body, they appear as various shades of white to pink (bone, nerves, cartilage, fat, connective tissue, and muscle) or red to deep red (blood vessels and more easily visible organs such as the liver, kidney, and spleen), thus leading to potential ambiguity during surgical dissection. Furthermore, open-eld surgery depends on the direct visualiza­tion of patient tissues, whereas in minimally invasive surgeries (i.e., microscopic, endoscopic, laparoscopic, and robotic surgery), patient’s tissues are visualized through an interface (viewed through the ocular eyepiece or using cameras and digital dis­plays). For the minimally invasive surgical procedures, the added hardware that is necessary for uorescence imaging can be tted into existing instrumentation. The emerging eld of uorescent surgical imaging promises to be a powerful enhancement to tradi­tional low-contrast white-light visualization, offering real-time highlighted delineation of complex anatomic structures. Improved visualization will lead to more complete removal of disease, decreased inadvertent injuries to vital structures, and improved identication for repair of damaged tissues [6].
In addition, working through an interface with cameras and instruments inserted into body cavities through narrow conduits has also sacriced tactile feedback of directly working with tissue and dissection along tissue planes. Thus, a medical specialty that is traditionally dependent on touch becomes even more dependent on vision. Thus, enhancing the visual differences between tissues by using uorescent probes based on structure or disease could be equated to color-coding the surgical eld. This is the reason why FGS could represent a major contribution to intraoperative decision- making during surgical procedures [7].
L. Baldari et al.
First Reports ofFluorescent Events
The rst description of uorescence dates to 1560 and 1565 by Bernardino de Sahagún and Nicolás Monardes, respectively. They
1 History andScience ofImmunouorescence
https://t.me/medicina_free
reported an early observation of uorescence in the lignum nephriticum infusion that was derived from the wood of the fol­lowing tree species: Pterocarpus indicus and Eysenhardtia polys- tachya. The chemical component emitting uorescence was the matlaline, derived from the oxidation of wood avonoids.
In 1819 and 1822, mineralogists Edward D.Clarke and René Just Haüy described uorescence in uorites, respectively. The phenomenon was described for chlorophyll by Sir David Brewster in 1833 and for quinine by Sir John Herschel in 1845.
In his 1852 article on “Refrangibility,” the British physicist and mathematician George Gabriel Stokes, noted for his studies of the behavior of viscous uids and for Stokes’ theorem, described the ability of uorspar and uranium glass to change invisible light beyond the violet end of the visible spectrum into blue light. This phenomenon was called “uorescence.” The name derives from the mineral uorite (calcium diuoride) that can contain traces of divalent europium that serves as the uorescent activator to emit blue light. In a fundamental experiment, a prism was used to iso­late ultraviolet radiation from sunlight and he observed blue light emitted by ethanol solution of quinine [8].
5
Preliminary Use ofFluorescence into Surgical Field
The rst clinical use of uorescence was in 1947, when it was used for identication of brain tumors during neurosurgery using the dye uorescein [9]. In 1953, Ray and Randall succeeded in detecting cancer cell in vaginal smears through a uorescent staining. The rationale behind the research was the afnity of the basic uorochrome dyes (berberine sulfate, acid fuchsin, and acri­dine) for nucleic acids. As neoplastic cells have an increase in total nucleic and ribonucleic acids, with an increase in protein synthesis, cancer cells were identied. A uorescent microscope was used to evidence this nding [10].
In 1955, Peck and Mack investigated the afnity of hematopor­phyrin for malignant tissue and its capability to evidence the bili­ary anatomy after biliary excretion through its uorescent properties. They used different spectra of the hematoporphyrin to
Соседние файлы в папке @xirurgi_2025